Navigate Up
UPMC/University of Pittsburgh Schools of the Health Sciences
For Journalists
Managers
Telephone: 412-647-9975
Other Inquiries


Pitt Researchers Find No Increase in Brain Cancer Related to Working at Connecticut Jet Engine Manufacturing Plant

PITTSBURGH, May 24, 2013 – Researchers at the University of Pittsburgh Graduate School of Public Health have concluded a 12-year, multi-part study into a perceived increase in brain cancer at the Pratt & Whitney jet engine manufacturing plant in North Haven, Conn., and have found no statistically significant elevations in the overall cancer rates among the workforce.
 
The results of the study, available online, will be published in the June edition of the Journal of Occupational and Environmental Medicine.
 
In May 2000, the Connecticut Department of Public Health (CTDPH) began an investigation of a reported increase in brain cancer at the North Haven facility and identified several cases of glioblastoma (GB), the most common form of brain cancer. A preliminary comparative cancer incidence analysis was inconclusive, and the CTDPH recommended Pratt & Whitney hire an independent research group to conduct a comprehensive study.
 
In July 2002, Gary Marsh, Ph.D., director of the Center for Occupational Biostatistics and Epidemiology, Pitt Public Health, and Nurtan Esmen, Ph.D., Division of Environmental and Occupational Health Sciences, University of Illinois at Chicago (UIC), began work on a large, multi-part investigation to determine whether mortality from or the incidence of central nervous system (CNS) neoplasms, or tumors, including GB, were elevated among workers at the North Haven plant or seven other Pratt & Whitney facilities serving as comparison sites, and whether those rates were associated with specific workplace exposures.
 
“Pitt Public Health and UIC researchers analyzed the records of almost a quarter million subjects over a 53-year period, making it one of the largest and most comprehensive cohort studies in an occupational setting,” said Dr. Marsh. “It also is the first large-scale study of workers in the jet engine manufacturing industry.”
 
Pitt epidemiologists and biostaticians studied the employment records and death certificates of more than 223,000 Pratt & Whitney workers employed during a period stretching from 1952 to 2001. Researchers identified 723 workers diagnosed with CNS neoplasms during 1976 to 2004. Those tumors were malignant, benign or unspecified, and included 277 GB cases. Researchers interviewed workers or available family members to gain more detailed information on behavioral and personal lifestyle factors. Low participation rates precluded analysis of this data, but the Pittsburgh case-control study provided the basis for a more refined assessment of workplace exposures.
 
The UIC exposure assessment considered 11 chemical or physical agents on the basis of known or suspected carcinogenic potential that could affect the central nervous system or other organs. UIC generated quantitative exposure estimates for soluble and mineral oil metalworking fluids, nickel, cobalt, chromium, solvents and a combustion aerosol generated during high-speed and high-temperature grinding that was unique to the North Haven plant. Researchers assigned qualitative exposures for ionizing radiation, electromagnetic fields, polychlorinated biphenyls and lead-cadmium. Exposure to one or more of 20 jet engine part families and 16 process categories created for the study also was assigned.
 
The UIC quantitative estimates showed workers had decreasing exposures to these chemicals over the course of the study period; in addition, the quantitative exposure levels were similar to or lower than those in published data from other industries.  
 
At the conclusion of the study, researchers found no statistically significant increase in overall CNS neoplasm rates among the Pratt & Whitney workforce as compared with the corresponding rates in the general populations of the U.S. and Connecticut. Comparisons among the five Pratt & Whitney plant groups revealed a slightly higher incidence of CNS neoplasms and GB among workers at the North Haven plant; however, further evaluation found no association with estimated workplace exposures.
 
“If not due to chance alone, the slightly elevated GB rates at the North Haven plant may reflect external occupational factors that we did not measure, or other factors unique to North Haven or the baseline plant used in the internal comparisons,” said Dr. Marsh.
 
During an overall evaluation of mortality rates from all causes of death, Pittsburgh and UIC researchers noted elevated chronic obstructive pulmonary disease (COPD)-related mortality rates in two of five plant groups studied, but found no association with the occupational factors examined in the study. Researchers could not rule out exposures workers received outside of the workplace, or other risk factors, such as smoking, as reasons for the observed COPD excesses.
 
Additional co-authors of this study include Ada O. Youk, Ph.D., Jeanine Buchanich, Ph.D., and Sarah Downing, B.S., Department of Biostatistics, Pitt Public Health; Kathleen J. Kennedy, M.S., and Roger P. Hancock, M.C.E., UIC Division of Environmental and Occupational Health Sciences; Steven E. Lacey, Ph.D., Department of Public Health, Indiana School of Medicine, Indianapolis; Jennifer S. Pierce, Ph.D., ChemRisk, LLC, Chicago; Mary Lou Fleissner, Dr.P.H., formerly with the CTDPH Division of Environmental Epidemiology and Occupational Health, Hartford.
 
The University of Pittsburgh and the University of Illinois at Chicago received funding from Pratt & Whitney for this research, but the design, conduct, analysis and conclusions are those of the authors.

©  UPMC | Affiliated with the University of Pittsburgh Schools of the Health Sciences
Supplemental content provided by A.D.A.M. Health Solutions. All rights reserved.

For help in finding a doctor or health service that suits your needs, call the UPMC Referral Service at 412-647-UPMC (8762) or 1-800-533-UPMC (8762). Select option 1.

UPMC is an equal opportunity employer. UPMC policy prohibits discrimination or harassment on the basis of race, color, religion, ancestry, national origin, age, sex, genetics, sexual orientation, marital status, familial status, disability, veteran status, or any other legally protected group status. Further, UPMC will continue to support and promote equal employment opportunity, human dignity, and racial, ethnic, and cultural diversity. This policy applies to admissions, employment, and access to and treatment in UPMC programs and activities. This commitment is made by UPMC in accordance with federal, state, and/or local laws and regulations.

Medical information made available on UPMC.com is not intended to be used as a substitute for professional medical advice, diagnosis, or treatment. You should not rely entirely on this information for your health care needs. Ask your own doctor or health care provider any specific medical questions that you have. Further, UPMC.com is not a tool to be used in the case of an emergency. If an emergency arises, you should seek appropriate emergency medical services.

For UPMC Mercy Patients: As a Catholic hospital, UPMC Mercy abides by the Ethical and Religious Directives for Catholic Health Care Services, as determined by the United States Conference of Catholic Bishops. As such, UPMC Mercy neither endorses nor provides medical practices and/or procedures that contradict the moral teachings of the Roman Catholic Church.

© UPMC
Pittsburgh, PA, USA UPMC.com